Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females 12 years or older
History of persistent bronchial asthma for at least 6 months
Documented use of an inhaled steroid or a combination of an inhaled steroid/long-acting beta 2 agonist for at least 1 month before screening
At screening, FEV1 of 60 to 90% predicted or 70 to 95% predicted for either ICS or ICS/LABA use respectively.Reversibility of FEV1 by at least 12% and 200 ml post-bronchodilator
Be able to use oral inhalers
Non-smokers
You may not be if
History of life-threatening asthma
Other pulmonary diseases; URI within 4 weeks before screening
Use of systemic steroids within 1 month before screening or more than 3 times in previous 6 months
Beta-adrenergic blocking agent use
More than 2 in-patient hospitalizations or ER visits due to asthma exacerbations in the prior year before screening
Pregnant or breast-feeding females
Females of child-bearing potential not using adequate means of birth control
Clinically relevant cardiovascular, hepatic, neurologic, endocrine, or other major systemic disease
Abnormal clinical laboratory parameters that would limit participation in the study or interfere with interpretation of study results
History of drug or alcohol abuse
Treatment with any investigational product within 30 days prior to study entry
Clareo Health | Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid
